Nevertheless, despite the increasing reference to academic and practitioners’ literature on investments in digital transformation, recent studies have shown that digital transformation initiatives are not always strategic orientated nor are they clearly defined, especially in the context of artificial intelligence (AI) use.
This project aimed to examine the process that organisations go through in order to achieve scalability in AI use, in their attempt to embrace digitalisation; and how this affects new product and service innovation. In particular, we were interested in understanding how a global organisation approaches digital transformation, particularly in the case of AI and identify the specific mechanisms that are adopted for the purpose of scalability.
Speakers : Nisreen Ameen, Senior Lecturer in Digital Marketing & Co-director of the Digital Organisation and Society Research Centre Royal Holloway – University of London.
Discussant :
Ingrid Dufour Bonami
Medical digital lead EMEA Bayer, Co-lead of Health Group for Impact AI
Marc Simon
Health manager for French local authority, Member of Health Group for Impact IA
The project is based on academic-industry partnership, with a global pharmaceutical firm.
The event will take place in room 3.216 on the Grand Paris Campus and
Teams.